Skip to main content

Peer Review reports

From: Effect of Tenofovir Alafenamide Fumarate on the outcomes of hospitalized COVID-19 patients: a prospective, block-balanced, open-label, randomized controlled trial

Original Submission
8 Jun 2024 Submitted Original manuscript
15 Jun 2024 Author responded Author comments - Ali Akbar Shayesteh
18 Jun 2024 Author responded Author comments - Ali Akbar Shayesteh
Resubmission - Version 2
15 Jun 2024 Submitted Manuscript version 2
9 Jul 2024 Author responded Author comments - Ali Akbar Shayesteh
Resubmission - Version 3
9 Jul 2024 Submitted Manuscript version 3
14 Jul 2024 Reviewed Reviewer Report
20 Jul 2024 Reviewed Reviewer Report
25 Jul 2024 Reviewed Reviewer Report
30 Jul 2024 Author responded Author comments - Ali Akbar Shayesteh
Resubmission - Version 4
30 Jul 2024 Submitted Manuscript version 4
8 Aug 2024 Reviewed Reviewer Report
10 Aug 2024 Reviewed Reviewer Report
12 Aug 2024 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
12 Aug 2024 Editorially accepted
17 Oct 2024 Article published 10.1186/s40360-024-00781-3

You can find further information about peer review here.

Back to article page